XJPX
6376
Market cap1.52bUSD
Oct 09, Last price
3,735.00JPY
1D
1.49%
1Q
0.95%
Jan 2017
236.18%
Name
Nikkiso Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nikkiso Co., Ltd. is a global enterprise that operates across a diverse range of sectors, including industrial solutions, aerospace components, precision instruments, deep ultraviolet (DUV) LED technology, and medical devices. The company's operations are primarily organized into two main divisions: the Industrial Business segment and the Medical Business segment. The Industrial Business segment focuses on the development, production, sales, and maintenance of specialized industrial pumps, such as leak-proof pumps, accurate metering pumps, and cryogenic pumps vital for liquefied natural gas (LNG) transfer. This division also provides advanced water conditioning systems for thermal and nuclear power plants, along with integrated system products that combine water treatment capabilities with automation and other sophisticated functions. Furthermore, it supplies warm laminating systems, various electronic component manufacturing equipment, carbon fiber reinforced plastic (CFRP) products designed for civilian aircraft, and deep ultraviolet LEDs and their associated technologies. Within the Medical Business segment, Nikkiso is engaged in the manufacturing, distribution, and servicing of products and medical supplies crucial for kidney-related therapies, including hemodialysis, peritoneal dialysis, and continuous renal replacement therapy. Its key offerings encompass comprehensive dialysis systems, dialyzers, blood tubing lines, and powdered dialysate. This segment also produces blood glucose monitoring devices, air purification units, innovative ozone-water hand-washing systems, and microwave-based surgical instruments. Founded in 1950 as Nippon Kikai Keiso Kaisha Ltd., the company officially changed its name to Nikkiso Co., Ltd. in November 1968. Its corporate headquarters are located in Tokyo, Japan.
Related entities
Subsidiaries (2)
Nikkiso Europe GmbH
Geveke Werktuigbouw B.V.
Key people
Toshihiko Kai
Chairman of the Board · since 2025
Koichi Kato
Executive President, Representative Director · since 2025
Takeshi Iwaoka
Executive Officer, Chief Director of Aerospace Business · since 2025
Kazuo Nakatsuru
Executive Officer · since 2025
Kazuhiko Sugimoto
Executive Officer, Manager of Medical Factory in Kanazawa Manufacturing Plant · since 2026
Kenji Tomura
Executive Officer, President of Western Japan Office · since 2019
Kyosuke Watanabe
Executive Officer · since 2021
Naoki Yokota
Executive Officer, Deputy Chief Director of Aerospace Business · since 2023
Yoshihiko Kinoshita
Executive Officer, Director of Nikkiso Technical Research Institute, Director · since 2023
Masaharu Murakami
Executive Officer, Manager of Corporate, Chief Director of Corporate, Director · since 2026
Kenji Saito
Managing Executive Officer, Manager of Industry Office, Chief Director of Industrial Business, Director · since 2025
Peter Wagner
Director · since 2024
Masaru Yamamura
Managing Executive Officer, Chief Director of Medical Business, Manager of Medical Care Office, Manager of Shizuoka Business Office, Director · since 2025
Atsuko Kikuchi
Independent Director · since 2025
Independent Director · since 2021
Junko Yamaguchi
Independent Director · since 2025
Headquarters & legal address
恵比寿四丁目20番3号
東京都 渋谷区 150-6022
JP
東京都 渋谷区 150-6022
JP
Address
20-3, Ebisu 4-Chome
Shibuya-ku Tokyo 150-6022
JP
Shibuya-ku Tokyo 150-6022
JP
Other language
NIKKISO CO., LTD.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||